Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound - Marketscreener.com
| ADVANC Stock | THB 285.00 1.00 0.35% |
About 62% of Advanced Info's investor base is looking to short. The analysis of current outlook of investing in Advanced Info Service suggests that many traders are alarmed regarding Advanced Info's prospects. The current market sentiment, together with Advanced Info's historical and current headlines, can help investors time the market. In addition, many technical investors use Advanced Info Service stock news signals to limit their universe of possible portfolio assets.
Advanced |
Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound Marketscreener.com
Read at news.google.com
 |
Advanced Info Fundamental Analysis
We analyze Advanced Info's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Advanced Info using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Advanced Info based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Advanced Info is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Advanced Info Service Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Advanced Info stock to make a market-neutral strategy. Peer analysis of Advanced Info could also be used in its relative valuation, which is a method of valuing Advanced Info by comparing valuation metrics with similar companies.
Peers
Advanced Info Related Equities
| STGT-R | SRI TRANG | 6.03 | ||||
| RBF-R | RB FOOD | 5.75 | ||||
| CH | Chin Huay | 2.00 | ||||
| AAI | Asian Alliance | 1.80 | ||||
| AEONTS-R | AEON Thana | 1.63 | ||||
| AEONTS | AEON Thana | 0.41 | ||||
| SKR | Sikarin Public | 0.53 |
Complementary Tools for Advanced Stock analysis
When running Advanced Info's price analysis, check to measure Advanced Info's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Info is operating at the current time. Most of Advanced Info's value examination focuses on studying past and present price action to predict the probability of Advanced Info's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Info's price. Additionally, you may evaluate how the addition of Advanced Info to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |